For immediate release
Monday, June 20, 2022
Press Relations Office
On June 18-19, the U.S. Agency for International Development (USAID), in collaboration with COVAX, delivered the first two U.S.-facilitated shipments of Pfizer’s COVID-19 pediatric vaccines to Mongolia (302,400 doses) and in Nepal (2.2 million doses). These pediatric vaccines are part of President Biden’s pledge to donate COVID-19 vaccine doses to countries around the world.
At the second COVID-19 Global Summit in May, the United States announced its commitment to expand our types of dose donations to include boosters and pediatric doses to accelerate global vaccine coverage and respond to the request from partner countries for pediatric doses to vaccinate children aged 5 to 11 years. . In collaboration with COVAX, USAID will now continue to ship pediatric doses to partner countries around the world that have requested them.
USAID helps countries address the public health impacts of COVID-19 by first achieving high immunization coverage among populations most at risk (i.e. health workers, elderly and immunocompromised people). Given the immediate availability of the global COVID-19 vaccine supply, USAID is working with interested partner countries to expand vaccination to other groups, including children.
Expanding vaccination to children can provide countries with opportunities to reach high-risk populations, such as grandparents; increase community acceptance; and contribute to positive standards for COVID-19 vaccination.
In addition to supporting pediatric COVID-19 vaccines, USAID continues its decades-long commitment to supporting essential immunization to protect children from vaccine-preventable diseases.
For the latest updates on USAID’s work on COVID-19, visit https://www.usaid.gov/coronavirus.